Islet cell autoimmunity and transplantation tolerance: Two distinct mechanisms?

Annals of the New York Academy of Sciences

Volumn 1005, Issue , 2003, Pages 148-156

  Pearson, Todd ^a   Markees, Thomas G ^a   Serreze, David V ^a,b   Pierce, Melissa A ^b   Wicker, Linda S ^c   Peterson, Laurence B ^d   Shultz, Leonard D ^a,b   Mordes, John P ^a   Rossini, Aldo A ^a,e   Greiner, Dale L ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b JACKSON LABORATORY   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d MERCK RESEARCH LABORATORIES   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

CD154; Costimulation blockade; NOD mice; Transplantation tolerance; Type 1 diabetes

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL TRANSPLANTATION; CONCEPT FORMATION; CONFERENCE PAPER; HUMAN; HYBRID; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTECTION;

ANIMALIA;

EID: 11144357867     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1288.016     Document Type: Conference Paper

References (29)

1. ROSSINI, A.A. & J.P. MORDES. 1994. Diabetes mellitus. In Office Practice of Medicine, pp. 558-590. Saunders. Philadelphia.
2. GABIR, M.M., R.L. HANSON, D. DABELEA et al. 2000. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23: 1108-1112.
3. SUTHERLAND, D.E.R., R.W.G. GRUESSNER & A.C. GRUESSNER. 2001. Pancreas transplantation for treatment of diabetes mellitus. World J. Surg. 25: 487-496.
4. SCHARP, D.W., P.E. LACY, J.V. SANTIAGO et al. 1990. Insulin independence after islet transplantation into type I diabetic patient. Diabetes 39: 515-518.
5. SHAPIRO, A.M.J., J.R.T. LAKEY, E.A. RYAN et al. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343: 230-238.
6. RYAN, E.A., J.R.T. LAKEY, B.W. PATY et al. 2002. Successful islet transplantation -continued insulin reserve provides long-term glycemic control. Diabetes 51: 2148-2157.
7. LAEDERACH-HOFMANN, K. & B. BUNZEL. 2000. Noncompliance in organ transplant recipients: a literature review. Gen. Hosp. Psychiatry 22: 412-424.
8. LOHMANN, T., C. LIST, P. LAMESCH et al. 2000. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunosuppressive therapy by FK506/Tacrolimus. Exp. Clin. Endocrinol. Diabetes 108: 347-352.
9. ROSSINI, A.A., D.L. GREINER & J.P. MORDES. 1999. Induction of immunological tolerance for transplantation. Physiol. Rev. 79: 99-141.
10. LIU, E. & G.S. EISENBARTH. 2002. Type 1A diabetes mellitus-associated autoimmunity. Endocrinol. Metab. Clin. North Am. 31: 391-410.
11. MORDES, J.P., D.V. SERREZE, D.L. GREINER & A.A. ROSSINI. 2003. Animal models of autoimmune diabetes mellitus: a fundamental and clinical text. In press.
12. MARKEES, T.G., D.V. SERREZE, N.E. PHILLIPS et al. 1999. NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes 48: 967-974.
13. MORDES, J.P., R. BORTELL, H. GROEN et al. 2001. Autoimmune diabetes mellitus in the BB rat. In Animal Models of Diabetes: A Primer. Vol. 2, pp. 1-41. Harwood Academic Pub. Amsterdam.
14. SERREZE, D.V. & E.H. LEITER. 2001. Genes and pathways underlying autoimmune diabetes in NOD mice. In Molecular Pathology of Insulin Dependent Diabetes Mellitus, p. 31. Karger. New York.
15. GREINER, D.L., A.A. ROSSINI & J.P. MORDES. 2001. Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor andprimum non nocere. Clin. Immunol. 100: 134-143.
16. HARA, M., C.I. KINGSLEY, M. NIIMI et al. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166: 3789-3796.
17. WILSON, S.B., S.C. KENT, K.T. PATTON et al. 1998. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 391: 177-181.
18. LEE, P.T., A. PUTNAM, K. BENLAGHA et al. 2002. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110: 793-800.
19. LEITER, E.H. 1998. NOD mice and related strains: origins, husbandry, and biology. In NOD Mice and Related Strains: Research Applications in Diabetes, AIDS, Cancer, and Other Diseases, pp. 1-36. Landes. Austin.
20. TODD, J.A. & L.S. WICKER. 2001. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 15: 387-395.
21. 2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice. Proc. Natl. Acad. Sci. USA 98: 11533-11538.
22. RYAN, E.A., J.R.T. LAKEY, R.V. RAJOTTE et al. 2001. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50: 710-719.
23. ELSTER, E.A., H. XU, D.K. TADAKI et al. 2001. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates. Transplantation 72: 1473-1478.
24. IWAKOSHI, N.N., T.G. MARKEES, N.A. TURGEON et al. 2001. Skin allograft maintenance in a new synchimeric model system of tolerance. J. Immunol. 167: 6623-6630.
25. + T cells, interferon-gamma, and CTLA4. J. Clin. Invest. 101: 2446-2455.
26. MOLANO, R.D., T. BERNEY, H. LI et al. 2001. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation. Diabetes 50: 270-276.
27. ATKINSON, M. & E.H. LEITER. 1999. The NOD mouse model of insulin dependent diabetes: as good as it gets? Nat. Med. 5: 601-604.
28. YUI, M.A., K. MURALIDHARAN, B. MORENO-ALTAMIRANO et al. 1996. Production of congenic mouse strains carrying NOD-derived diabetogenic genetic intervals: an approach for the genetic dissection of complex traits. Mamm. Genome 7: 331-334.
29. PEARSON, T., T.G. MARKEES, L.S. WICKER et al. 2003. NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance induction. Diabetes 52: 321-326.